Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transitionSara Monteiro‐Reis, Cármen Jerónimo, Isabelle Bernard‐Pierrot et al.|International Journal of Biological Sciences|2022Cited by 25
Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategiesNicole Viveiros, Cármen Jerónimo, Bianca C. T. Flores et al.|Clinical & Translational Immunology|2022Cited by 24
Downregulation of m <sup>6</sup> A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressivenessCatarina Guimarães‐Teixeira, Cármen Jerónimo, João Lobo et al.|Molecular Oncology|2022Cited by 20
Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progressionCláudia Martins‐Lima, Cármen Jerónimo, Vera Miranda‐Gonçalves et al.|Cellular Oncology|2022Cited by 8